首頁 > 市場調查報告書 > 醫療設備

心血管設備

心臟植入市場規模、佔有率和成長分析（按設備類型、應用、最終用戶和地區分類）：產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898144

心臟植入市場規模、佔有率和成長分析（按設備類型、應用、最終用戶和地區分類）：產業預測（2026-2033 年）

Cardiac Implants Market Size, Share, and Growth Analysis, By Device Type (Pacemaker Devices, Cardiac Resynchronization Therapy Devices), By Application (Arrhythmias, Myocardial Ischemia), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球心臟植入市場規模預計在 2024 年達到 171.1 億美元，從 2025 年的 181.9 億美元成長到 2033 年的 296.5 億美元，在預測期（2026-2033 年）內複合年成長率為 6.3%。

全球心臟植入市場正經歷強勁成長，這主要得益於心血管疾病發生率的上升、技術的進步以及人口老化。久坐不動的生活方式、肥胖和糖尿病等風險因素導致心血管疾病發病率不斷攀升，從而推動了對能夠改善患者生活品質的有效治療方法的需求。小型化和無線連接等技術創新正在推動更有效率、更人性化的產品（例如心臟節律器和去心房顫動）的研發。然而，高成本、嚴格的監管要求以及對設備長期性能的擔憂等挑戰可能會阻礙市場擴張和普及，因此，持續改進設備設計和監管流程以確保患者安全和最佳治療效果至關重要。

推動全球心臟植入市場發展的因素

心血管疾病（包括心臟衰竭、心律不整和冠狀動脈疾病）發生率的不斷上升是全球心臟植入市場的主要驅動力。久坐不動的生活方式、不良飲食習慣和人口老化等因素共同導致了這些疾病的盛行率上升。隨著心血管疾病負擔的持續加重，對先進心臟植入的需求也在不斷成長，這凸顯了開發創新醫療解決方案以有效應對這些健康挑戰並改善患者預後的迫切需求。這種日益成長的緊迫性反映了透過心臟植入治療的技術進步來促進心臟健康和控制心血管疾病的更廣泛趨勢。

限制全球心臟植入市場的因素

全球心臟植入市場面臨許多限制因素，其中最主要的限制因素是與這些醫療設備相關的嚴格監管核准程序。遵守各監管機構制定的嚴格合規標準會延長核准流程並增加成本。這個複雜的流程可能會阻礙創新技術的及時推出，並影響市場發展。由於企業需要努力遵守這些複雜的法規，新型和改良型心臟植入解決方案的推出可能會被延遲，最終阻礙市場的整體成長和活力。

全球心臟植入市場趨勢

全球心臟植入市場正日益受到遠端監測和數位健康解決方案融合的影響。這一趨勢提升了醫療服務提供者遠端監測患者心臟健康和設備性能的能力，從而實現及時干預和個人化護理。遠端監測系統可望顯著降低醫院再入院率，進而改善病患管理和治療效果。向數位健康技術的轉變正在重新定義病人參與和護理服務模式，最終形成一種更積極主動的心臟健康管理方法，並促進心臟植入行業的整體成長。

美敦力（美國）
雅培實驗室（美國）
波士頓科學公司（美國）
Biotronik SE & Co. KG（德國）
樂普醫療科技有限公司（中國）
LivaNova PLC（英國）
奧西普卡股份公司（德國）
Oscor Inc.（美國）
Pacetronix（印度）
Medico SpA（義大利）
微創醫療（中國）
Shree Pacetronix 有限公司（印度）
Biotricity公司（美國）
心臟科學公司（美國）
EBR Systems, Inc.（美國）
Jarvik Heart, Inc.（美國）
柏林心臟有限公司（德國）
ReliantHeart 公司（美國）
SynCardia Systems, LLC（美國）
BiVacor（美國）

結論與建議

簡介目錄

Product Code: SQMIG35A2355

Global Cardiac Implants Market size was valued at USD 17.11 Billion in 2024 and is poised to grow from USD 18.19 Billion in 2025 to USD 29.65 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global cardiac implants market is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, advancements in technology, and a growing aging population. The rising incidence of cardiovascular conditions, attributed to sedentary lifestyles and risk factors such as obesity and diabetes, fuels demand for effective treatment options that enhance patients' quality of life. Technological innovations in implantable devices, including miniaturization and wireless connectivity, have led to the development of more efficient and user-friendly products like pacemakers and defibrillators. Despite this growth, challenges such as high costs, stringent regulatory requirements, and concerns about long-term device performance can hinder market expansion and accessibility, underscoring the need for ongoing improvements in device design and regulatory processes to ensure patient safety and optimal outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Implants Market Segments Analysis

Global Cardiac Implants Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve and Others. Based on Application, the market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Implants Market

The increasing occurrence of cardiovascular diseases, notably heart failure, arrhythmias, and coronary artery disease, significantly fuels the global cardiac implants market. Contributing factors include sedentary lifestyles, poor dietary choices, and an aging population, which collectively escalate the prevalence of these conditions. As the burden of cardiovascular issues continues to rise, the demand for advanced cardiac implants grows, highlighting the critical need for innovative medical solutions to address these health challenges effectively and improve patient outcomes. This growing urgency reflects the broader trend towards enhancing heart health and managing cardiovascular conditions through technological advancements in cardiac implant therapies.

Restraints in the Global Cardiac Implants Market

The global cardiac implants market faces significant constraints due to the rigorous regulatory approval procedures associated with these medical devices. The necessity to adhere to strict compliance standards established by various regulatory agencies can result in lengthy and expensive approval timelines. This extensive process may hinder the timely launch of innovative technologies, impeding advancements in the market. As companies navigate through these complex regulations, the potential for introducing new and improved cardiac implant solutions may be delayed, ultimately affecting the overall growth and dynamism of the market.

Market Trends of the Global Cardiac Implants Market

The Global Cardiac Implants market is increasingly influenced by the integration of remote monitoring and digital health solutions. This trend enhances the capability of healthcare providers to monitor patients' cardiac health and the performance of devices from afar, facilitating timely interventions and tailored care. With remote monitoring systems, there is a substantial reduction in hospital readmissions, leading to improved patient management and outcomes. This shift towards digital health technologies is redefining patient engagement and care delivery models, ultimately creating a more proactive approach to cardiac health management and contributing to the overall growth of the cardiac implants sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Cardiac Implants Market Size by Device Type & CAGR (2026-2033)

Market Overview
Pacemaker Devices
Cardiac Resynchronization Therapy Devices
Implantable Hemodynamic Monitoring Devices
Implanted Heart Rhythm Monitors
Coronary Stents
Implantable Cardioverter Defibrillator
Heart Valve
Others

Global Cardiac Implants Market Size by Application & CAGR (2026-2033)

Market Overview
Arrhythmias
Myocardial Ischemia
Acute Myocardial Infraction
Congestive Heart Failure
Others

Global Cardiac Implants Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Cardiac Implants Market Size & CAGR (2026-2033)

North America (Device Type, Application, End User)
- US
- Canada
Europe (Device Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotricity Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EBR Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReliantHeart Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVacor (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments